Sirtuin modulating imidazothiazole compounds

Details for Australian Patent Application No. 2008266746 (hide)

Owner Sirtris Pharmaceuticals, Inc.

Inventors Lunsmann, Walter Joseph; Jirousek, Michael; Bemis, Jean; Disch, Jeremy S.; Vu, Chi B.; Ng, Pui Yee

Agent Davies Collison Cave

Pub. Number AU-B-2008266746

PCT Pub. Number WO2008/156866

Priority 60/936,633 20.06.07 US

Filing date 20 June 2008

Wipo publication date 24 December 2008

Acceptance publication date 15 March 2012

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

4 February 2010 PCT application entered the National Phase

  PCT publication WO2008/156866 Priority application(s): WO2008/156866

15 March 2012 Application Accepted

  Published as AU-B-2008266746

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266749-Sirtuin modulating thiazolopyridine compounds

2008266745-Joint destruction biomarkers for antiIL-17A therapy of inflammatory joint disease